Telomere length and outcomes in ischaemic heart failure: Data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA)

European Journal of Heart Failure

Volumn 17, Issue 3, 2015, Pages 313-319

  Haver, Vincent G ^a   Mateo Leach, Irene ^a   Kjekshus, John ^b   Fox, Jayne C ^c   Wedel, Hans ^d   Wikstrand, John ^e   De Boer, Rudolf A ^a   Van Gilst, Wiek H ^a   McMurray, John J V ^f   Van Veldhuisen, Dirk J ^a   Van Der Harst, Pim ^a,g  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c ASTRAZENECA   (United Kingdom)

^d NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Ageing; Healthy ageing; Heart failure; Leucocyte telomere length

Indexed keywords

CREATININE; PLACEBO; ROSUVASTATIN; BIOLOGICAL MARKER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC ISCHAEMIC SYSTOLIC HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SMOKING; SURVIVAL; SYSTOLIC HEART FAILURE; TELOMERE; TELOMERE HOMEOSTASIS; AGING; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; GENETICS; HEART FAILURE; MORTALITY; MULTICENTER STUDY; MYOCARDIAL ISCHEMIA; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; BIOMARKERS; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LEUKOCYTES; MALE; MYOCARDIAL ISCHEMIA; RETROSPECTIVE STUDIES; ROSUVASTATIN CALCIUM; TELOMERE;

EID: 84924290020     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.237     Document Type: Article

References (30)

1. Wong LS, de Boer RA, Samani NJ, van Veldhuisen DJ, van der Harst P,. Telomere biology in heart failure. Eur J Heart Fail 2008; 10: 1049-1056.
2. Serra V, Grune T, Sitte N, Saretzki G, von Zglinicki T,. Telomere length as a marker of oxidative stress in primary human fibroblast cultures. Ann NY Acad Sci 2000; 908: 327-330.
3. Huzen J, Wong LS, van Veldhuisen DJ, Samani NJ, Zwinderman AH, Codd V, Cawthon RM, Benus GF, van der Horst IC, Navis G, Bakker SJ, Gansevoort RT, de Jong PE, Hillege HL, van Gilst WH, de Boer RA, van der Harst P,. Telomere length loss due to smoking and metabolic traits. J Intern Med 2014; 275: 155-163.
4. Olovnikov AM,. Telomeres, telomerase, and aging: origin of the theory. Exp Gerontol 1996; 31: 443-448.
5. Wong LS, van der Harst P, de Boer RA, Huzen J, van Gilst WH, van Veldhuisen DJ,. Aging, telomeres and heart failure. Heart Fail Rev 2010; 15: 479-486.
6. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P,. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012; 14: 803-869.
7. Zhu H, Belcher M, van der Harst P,. Healthy aging and disease: role for telomere biology? Clin Sci (Lond) 2011; 120: 427-440.
8. Leri A, Franco S, Zacheo A, Barlucchi L, Chimenti S, Limana F, Nadal-Ginard B, Kajstura J, Anversa P, Blasco MA,. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J 2003; 22: 131-139.
9. van der Harst P, van der Steege G, de Boer RA, Voors AA, Hall AS, Mulder MJ, van Gilst WH, van Veldhuisen DJ, MERIT-HF Study Group. Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol 2007; 49: 1459-1464.
10. van der Harst P, de Boer RA, Samani NJ, Wong LS, Huzen J, Codd V, Hillege HL, Voors AA, van Gilst WH, Jaarsma T, van Veldhuisen DJ,. Telomere length and outcome in heart failure. Ann Med 2010; 42: 36-44.
11. Kjekshus J, Apetrei E, Barrios V, Bohm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Janosi A, Kamensky G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J, CORONA Group. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007; 357: 2248-2261.
12. Rickham PP,. Human experimentation. Code of ethics of the World Medical Association. Declaration of Helsinki. Br Med J 1964; 2: 177.
13. Cawthon RM,. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 2009; 37: e21.
14. Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, Marlin R, Frenda SJ, Magbanua MJ, Daubenmier J, Estay I, Hills NK, Chainani-Wu N, Carroll PR, Blackburn EH,. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol 2013; 14: 1112-1120.
15. Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, Shepherd J, Packard CJ, Samani NJ,. West of Scotland Coronary Prevention Study Group. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 2007; 369: 107-114.
16. Saliques S, Teyssier JR, Vergely C, Lorgis L, Lorin J, Farnier M, Donzel A, Sicard P, Berchoud J, Lagrost AC, Touzery C, Ragot S, Cottin Y, Rochette L, Zeller M,. Circulating leukocyte telomere length and oxidative stress: a new target for statin therapy. Atherosclerosis 2011; 219: 753-760.
17. Codd V, Nelson CP, Albrecht E, Mangino M, Deelen J, Buxton JL, Hottenga JJ, Fischer K, Esko T, Surakka I, Broer L, Nyholt DR, Mateo Leach I, Salo P, Hagg S, Matthews MK, Palmen J, Norata GD, O'Reilly PF, Saleheen D, Amin N, Balmforth AJ, Beekman M, de Boer RA, Bohringer S, Braund PS, Burton PR, de Craen AJ, Denniff M, Dong Y, Douroudis K, Dubinina E, Eriksson JG, Garlaschelli K, Guo D, Hartikainen AL, Henders AK, Houwing-Duistermaat JJ, Kananen L, Karssen LC, Kettunen J, Klopp N, Lagou V, van Leeuwen EM, Madden PA, Magi R, Magnusson PK, Mannisto S, McCarthy MI, Medland SE, Mihailov E, Montgomery GW, Oostra BA, Palotie A, Peters A, Pollard H, Pouta A, Prokopenko I, Ripatti S, Salomaa V, Suchiman HE, Valdes AM, Verweij N, Vinuela A, Wang X, Wichmann HE, Widen E, Willemsen G, Wright MJ, Xia K, Xiao X, van Veldhuisen DJ, Catapano AL, Tobin MD, Hall AS, Blakemore AI, van Gilst WH, Zhu H, Consortium C, Erdmann J, Reilly MP, Kathiresan S, Schunkert H, Talmud PJ, Pedersen NL, Perola M, Ouwehand W, Kaprio J, Martin NG, van Duijn CM, Hovatta I, Gieger C, Metspalu A, Boomsma DI, Jarvelin MR, Slagboom PE, Thompson JR, Spector TD, van der Harst P, Samani NJ,. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet 2013; 45: 422-7, 427e1-2.
18. Fitzpatrick AL, Kronmal RA, Kimura M, Gardner JP, Psaty BM, Jenny NS, Tracy RP, Hardikar S, Aviv A,. Leukocyte telomere length and mortality in the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci 2011; 66: 421-429.
19. Kimura M, Hjelmborg JV, Gardner JP, Bathum L, Brimacombe M, Lu X, Christiansen L, Vaupel JW, Aviv A, Christensen K,. Telomere length and mortality: a study of leukocytes in elderly Danish twins. Am J Epidemiol 2008; 167: 799-806.
20. Svensson J, Karlsson MK, Ljunggren O, Tivesten A, Mellstrom D, Moverare-Skrtic S,. Leukocyte telomere length is not associated with mortality in older men. Exp Gerontol 2014; 57: 6-12.
21. Farzaneh-Far R, Cawthon RM, Na B, Browner WS, Schiller NB, Whooley MA,. Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: data from the Heart and Soul Study. Arterioscler Thromb Vasc Biol 2008; 28: 1379-1384.
22. O'Donovan A, Pantell MS, Puterman E, Dhabhar FS, Blackburn EH, Yaffe K, Cawthon RM, Opresko PL, Hsueh WC, Satterfield S, Newman AB, Ayonayon HN, Rubin SM, Harris TB, Epel ES,. Health Aging and Body Composition Study. Cumulative inflammatory load is associated with short leukocyte telomere length in the Health, Aging and Body Composition Study. PLoS One 2011; 6: e19687.
23. Olivieri F, Mazzanti I, Abbatecola AM, Recchioni R, Marcheselli F, Procopio AD, Antonicelli R,. Telomere/telomerase system: a new target of statins pleiotropic effect? Curr Vasc Pharmacol 2012; 10: 216-224.
24. van der Harst P, Wong LS, de Boer RA, Brouilette SW, van der Steege G, Voors AA, Hall AS, Samani NJ, Wikstrand J, van Gilst WH, van Veldhuisen DJ, MERIT-HF Study Group. Possible association between telomere length and renal dysfunction in patients with chronic heart failure. Am J Cardiol 2008; 102: 207-210.
25. Wong LS, van der Harst P, de Boer RA, Codd V, Huzen J, Samani NJ, Hillege HL, Voors AA, van Gilst WH, Jaarsma T, van Veldhuisen DJ,. Renal dysfunction is associated with shorter telomere length in heart failure. Clin Res Cardiol 2009; 98: 629-634.
26. Bansal N, Whooley MA, Regan M, McCulloch CE, Ix JH, Epel E, Blackburn E, Lin J, Hsu CY,. Association between kidney function and telomere length: the Heart and Soul study. Am J Nephrol 2012; 36: 405-411.
27. Butler MG, Tilburt J, DeVries A, Muralidhar B, Aue G, Hedges L, Atkinson J, Schwartz H,. Comparison of chromosome telomere integrity in multiple tissues from subjects at different ages. Cancer Genet Cytogenet 1998; 105: 138-144.
28. Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A, Yasuzawa-Amano S, Trofimova I, Siggins RW, Lecapitaine N, Cascapera S, Beltrami AP, D'Alessandro DA, Zias E, Quaini F, Urbanek K, Michler RE, Bolli R, Kajstura J, Leri A, Anversa P,. Human cardiac stem cells. Proc Natl Acad Sci USA 2007; 104: 14068-14073.
29. Cesselli D, Beltrami AP, D'Aurizio F, Marcon P, Bergamin N, Toffoletto B, Pandolfi M, Puppato E, Marino L, Signore S, Livi U, Verardo R, Piazza S, Marchionni L, Fiorini C, Schneider C, Hosoda T, Rota M, Kajstura J, Anversa P, Beltrami CA, Leri A,. Effects of age and heart failure on human cardiac stem cell function. Am J Pathol 2011; 179: 349-366.
30. Kroenke CH, Pletcher MJ, Lin J, Blackburn E, Adler N, Matthews K, Epel E,. Telomerase, telomere length, and coronary artery calcium in black and white men in the CARDIA study. Atherosclerosis 2012; 220: 506-512.